Summary
GlobalData's Medical Devices sector report, “Coronary Artery Bypass Graft Surgery - Medical Devices Pipeline Assessment, 2016" provides an overview of Coronary Artery Bypass Graft Surgery currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Coronary Artery Bypass Graft Surgery pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Coronary Artery Bypass Graft Surgery under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Coronary Artery Bypass Graft Surgery and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Coronary Artery Bypass Graft Surgery under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Companies Mentioned
AdvanSource Biomaterials Corporation
Axcelon Biopolymers Corp.
CardioPolymers, Inc.
CellProthera
Coromedic Ltd.
Cytograft Tissue Engineering, Inc.
Elana bv
Endogene Ltd
Graft-Loc Inc.
H. Lee Moffitt Cancer Center & Research Institute, Inc.
iiTech BV
Magenta Medical Inc
Miracor Medical Systems GmbH
Neograft Technologies, Inc.
NuVascular Technologies Inc
Prekubator TTO
Revivicor, Inc.
SeamVad Ltd.
St. Jude Medical, Inc.
Tengion, Inc.
The University of Utah
Tissue Regeneration Technologies, LLC
University College London
University of Arizona
University of California, Los Angeles
'
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Introduction 7
2.1 Coronary Artery Bypass Graft Surgery Overview 7
3 Products under Development 8
3.1 Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development 8
3.2 Coronary Artery Bypass Graft Surgery - Pipeline Products by Segment 9
3.3 Coronary Artery Bypass Graft Surgery - Pipeline Products by Territory 10
3.4 Coronary Artery Bypass Graft Surgery - Pipeline Products by Regulatory Path 11
3.5 Coronary Artery Bypass Graft Surgery - Pipeline Products by Estimated Approval Date 12
3.6 Coronary Artery Bypass Graft Surgery - Ongoing Clinical Trials 13
4 Coronary Artery Bypass Graft Surgery - Pipeline Products under Development by Companies 14
4.1 Coronary Artery Bypass Graft Surgery Companies - Pipeline Products by Stage of Development 14
4.2 Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development 16
5 Coronary Artery Bypass Graft Surgery Companies and Product Overview 17
5.1 AdvanSource Biomaterials Corporation Company Overview 17
5.1.1 AdvanSource Biomaterials Corporation Pipeline Products & Ongoing Clinical Trials Overview 17
5.2 Axcelon Biopolymers Corp. Company Overview 20
5.2.1 Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview 20
5.3 CardioPolymers, Inc. Company Overview 21
5.3.1 CardioPolymers, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
5.4 CellProthera Company Overview 22
5.4.1 CellProthera Pipeline Products & Ongoing Clinical Trials Overview 22
5.5 Coromedic Ltd. Company Overview 24
5.5.1 Coromedic Ltd. Pipeline Products & Ongoing Clinical Trials Overview 24
5.6 Cytograft Tissue Engineering, Inc. Company Overview 26
5.6.1 Cytograft Tissue Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
5.7 Elana bv Company Overview 28
5.7.1 Elana bv Pipeline Products & Ongoing Clinical Trials Overview 28
5.8 Endogene Ltd Company Overview 29
5.8.1 Endogene Ltd Pipeline Products & Ongoing Clinical Trials Overview 29
5.9 Graft-Loc Inc. Company Overview 31
5.9.1 Graft-Loc Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
5.10 H. Lee Moffitt Cancer Center & Research Institute, Inc. Company Overview 32
5.10.1 H. Lee Moffitt Cancer Center & Research Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
5.11 iiTech BV Company Overview 34
5.11.1 iiTech BV Pipeline Products & Ongoing Clinical Trials Overview 34
5.12 Magenta Medical Inc Company Overview 37
5.12.1 Magenta Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 37
5.13 Miracor Medical Systems GmbH Company Overview 38
5.13.1 Miracor Medical Systems GmbH Pipeline Products & Ongoing Clinical Trials Overview 38
5.14 Neograft Technologies, Inc. Company Overview 40
5.14.1 Neograft Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
5.15 NuVascular Technologies Inc Company Overview 44
5.15.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 44
5.16 Prekubator TTO Company Overview 45
5.16.1 Prekubator TTO Pipeline Products & Ongoing Clinical Trials Overview 45
5.17 Revivicor, Inc. Company Overview 46
5.17.1 Revivicor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
5.18 SeamVad Ltd. Company Overview 47
5.18.1 SeamVad Ltd. Pipeline Products & Ongoing Clinical Trials Overview 47
5.19 St. Jude Medical, Inc. Company Overview 48
5.19.1 St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
5.20 Tengion, Inc. Company Overview 50
5.20.1 Tengion, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
5.21 The University of Utah Company Overview 51
5.21.1 The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 51
5.22 Tissue Regeneration Technologies, LLC Company Overview 52
5.22.1 Tissue Regeneration Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 52
5.23 University College London Company Overview 54
5.23.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 54
5.24 University of Arizona Company Overview 55
5.24.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 55
5.25 University of California, Los Angeles Company Overview 57
5.25.1 University of California, Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 57
6 Coronary Artery Bypass Graft Surgery- Recent Developments 58
6.1 Jan 04, 2016: Cellular Regenerative Therapy Greeted by French Minister of Health 58
6.2 Dec 15, 2015: Cardiac Dimensions Announces Appointment Of Gregory D. Casciaro As President And Chief Executive Officer 58
6.3 Aug 27, 2015: Bioheart to Change Name to U.S. Stem Cell, Inc. 59
6.4 Aug 06, 2015: Kips Bay Medical Provides Business Update and Reports Second Quarter 2015 Results 59
6.5 May 20, 2015: Primary Lesion Treatment Using Diamondback 360 Orbital Atherectomy System Enhances Paclitaxel Deposition in Calcified Peripheral Arteries: Preclinical Data Presented at EuroPCR 2015 61
6.6 May 19, 2015: Cardiovascular Systems Peripheral and Coronary Data Featured at EuroPCR 2015 62
6.7 May 12, 2015: Kips Bay Medical Provides Clinical Trial Update and Reports First Quarter 2015 Results 62
6.8 May 06, 2015: Bioheart Highlights Positive First Quarter Results 64
7 Appendix 65
7.1 Methodology 65
7.2 About GlobalData 67
7.3 Contact Us 68
7.4 Disclaimer 68
1.1 List of Tables
Table 1: Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development 8
Table 2: Coronary Artery Bypass Graft Surgery - Pipeline Products by Segment 9
Table 3: Coronary Artery Bypass Graft Surgery - Pipeline Products by Territory 10
Table 4: Coronary Artery Bypass Graft Surgery - Pipeline Products by Regulatory Path 11
Table 5: Coronary Artery Bypass Graft Surgery - Pipeline Products by Estimated Approval Date 12
Table 6: Coronary Artery Bypass Graft Surgery - Ongoing Clinical Trials 13
Table 7: Coronary Artery Bypass Graft Surgery Companies - Pipeline Products by Stage of Development 14
Table 8: Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development 16
Table 9: AdvanSource Biomaterials Corporation Pipeline Products & Ongoing Clinical Trials Overview 17
Table 10: CardioPass - Product Status 17
Table 11: CardioPass - Product Description 17
Table 12: AdvanSource Biomaterials Corporation - Ongoing Clinical Trials Overview 18
Table 13: CardioPass - CardioPass - European Clinical Trial 19
Table 14: Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview 20
Table 15: BNC - PVA Based Vascular Graft - Product Status 20
Table 16: BNC - PVA Based Vascular Graft - Product Description 20
Table 17: CardioPolymers, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
Table 18: Plexisyl-AF - Product Status 21
Table 19: Plexisyl-AF - Product Description 21
Table 20: CellProthera Pipeline Products & Ongoing Clinical Trials Overview 22
Table 21: CellProthera Automated Device - Product Status 23
Table 22: CellProthera Automated Device - Product Description 23
Table 23: Coromedic Ltd. Pipeline Products & Ongoing Clinical Trials Overview 24
Table 24: Distal Anastomosis Device - Product Status 24
Table 25: Distal Anastomosis Device - Product Description 24
Table 26: Proximal Anastomosis Device - Product Status 25
Table 27: Proximal Anastomosis Device - Product Description 25
Table 28: Cytograft Tissue Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
Table 29: LifeLine TEBV - CABG - Product Status 27
Table 30: LifeLine TEBV - CABG - Product Description 27
Table 31: Elana bv Pipeline Products & Ongoing Clinical Trials Overview 28
Table 32: Artificial Vessel - Product Status 28
Table 33: Artificial Vessel - Product Description 28
Table 34: Endogene Ltd Pipeline Products & Ongoing Clinical Trials Overview 29
Table 35: Cardio-Vascular Stapling Instrument - Product Status 30
Table 36: Cardio-Vascular Stapling Instrument - Product Description 30
Table 37: Graft-Loc Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
Table 38: Graft-Loc Device - Product Status 31
Table 39: Graft-Loc Device - Product Description 31
Table 40: H. Lee Moffitt Cancer Center & Research Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
Table 41: Vascular Stent - Product Status 33
Table 42: Vascular Stent - Product Description 33
Table 43: iiTech BV Pipeline Products & Ongoing Clinical Trials Overview 34
Table 44: S² Distal Anastomotic System - Product Status 35
Table 45: S² Distal Anastomotic System - Product Description 35
Table 46: S² Proximal Anastomotic System - Product Status 36
Table 47: S² Proximal Anastomotic System - Product Description 36
Table 48: Magenta Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 37
Table 49: Magenta Device - Congestive Heart Failure - Product Status 37
Table 50: Magenta Device - Congestive Heart Failure - Product Description 37
Table 51: Miracor Medical Systems GmbH Pipeline Products & Ongoing Clinical Trials Overview 38
Table 52: PiCSOAMI Impulse Console - CABG - Product Status 39
Table 53: PiCSOAMI Impulse Console - CABG - Product Description 39
Table 54: Neograft Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
Table 55: Angioshield - Product Status 41
Table 56: Angioshield - Product Description 41
Table 57: Neograft Technologies, Inc. - Ongoing Clinical Trials Overview 42
Table 58: Angioshield - Feasibility Study to Demonstrate the Safety of the Angioshield System to Provide Mechanical Support for Vein Grafts Used in CABG Surgery: THE ANGIOSHIELD STUDY 43
Table 59: Angioshield - First-In-Human Study to Demonstrate the Preliminary Safety and Efficacy of the Angioshield System to Provide Mechanical Support for Vein Grafts Used in CABG Surgery 43
Table 60: NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 44
Table 61: BioFunc - APC Vascular Graft - Product Status 44
Table 62: BioFunc - APC Vascular Graft - Product Description 44
Table 63: Prekubator TTO Pipeline Products & Ongoing Clinical Trials Overview 45
Table 64: Snapcon - Product Status 45
Table 65: Snapcon - Product Description 45
Table 66: Revivicor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
Table 67: Blood Vessel - Product Status 46
Table 68: Blood Vessel - Product Description 46
Table 69: SeamVad Ltd. Pipeline Products & Ongoing Clinical Trials Overview 47
Table 70: MySide - Product Status 47
Table 71: MySide - Product Description 47
Table 72: St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
Table 73: Automated Anastomosis Device - Product Status 49
Table 74: Automated Anastomosis Device - Product Description 49
Table 75: Tengion, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
Table 76: Neo-Vessel Replacement - Coronary Artery Bypass - Product Status 50
Table 77: Neo-Vessel Replacement - Coronary Artery Bypass - Product Description 50
Table 78: The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 51
Table 79: Automated Arterial Anastomotic Device - Product Status 51
Table 80: Automated Arterial Anastomotic Device - Product Description 51
Table 81: Tissue Regeneration Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 52
Table 82: Cardiogold - Product Status 53
Table 83: Cardiogold - Product Description 53
Table 84: University College London Pipeline Products & Ongoing Clinical Trials Overview 54
Table 85: Small Diameter Conduit - Product Status 54
Table 86: Small Diameter Conduit - Product Description 54
Table 87: University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 55
Table 88: Vascular Anastomosis Device - Product Status 56
Table 89: Vascular Anastomosis Device - Product Description 56
Table 90: University of California, Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 57
Table 91: Sutureless Anastomosis Device - Product Status 57
Table 92: Sutureless Anastomosis Device - Product Description 57
Table 93: Glossary 66
1.2 List of Figures
Figure 1: Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development 8
Figure 2: Coronary Artery Bypass Graft Surgery - Pipeline Products by Segment 9
Figure 3: Coronary Artery Bypass Graft Surgery - Pipeline Products by Territory 10
Figure 4: Coronary Artery Bypass Graft Surgery - Pipeline Products by Regulatory Path 11
Figure 5: Coronary Artery Bypass Graft Surgery - Pipeline Products by Estimated Approval Date 12
Figure 6: Coronary Artery Bypass Graft Surgery - Ongoing Clinical Trials 13
